New Zealand markets closed

bioAffinity Technologies, Inc. (BIAFW)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.5900+0.1200 (+25.53%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
4,938
2,532
4.803
0
0
Cost of revenue
3,314
1,741
0.467
0
-
Gross profit
1,624
791.615
4.336
0
-
Operating expenses
Research development
1,778
1,725
1,524
1,138
1,610
Selling general and administrative
7,829
6,791
2,481
1,069
994.343
Total operating expenses
9,984
8,765
4,015
2,207
2,604
Operating income or loss
-8,360
-7,973
-4,011
-2,207
-2,604
Interest expense
59.02
37.125
2,533
1,002
382.171
Total other income/expenses net
-
-27.796
-1,655
-3,116
-4,281
Income before tax
-8,353
-7,916
-8,152
-6,324
-7,266
Income tax expense
12.846
20.993
2.459
1.95
2.75
Income from continuing operations
-8,366
-7,937
-8,154
-6,326
-7,269
Net income
-8,366
-7,937
-8,154
-6,326
-7,269
Net income available to common shareholders
-8,366
-7,937
-8,154
-6,326
-7,269